Dosimetric risk estimates of radiation-induced malignancies after intensity modulated radiotherapy

Journal of Cancer Research and Therapeutics

Volumn 6, Issue 4, 2010, Pages 442-447

  Patil, Vijay M ^a   Kapoor, Rakesh ^a   Chakraborty, Santam ^a   Ghoshal, Sushmita ^a   Oinam, Arun S ^a   Sharma, Suresh C ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Dose response relationship; intensity modulated radiotherapy; radiation induced cancer; risk assessment; therapy related cancer

Indexed keywords

CARCINOGEN;

ADULT; AGED; ARTICLE; BENIGN TUMOR; BLADDER CANCER; BRAIN CANCER; CANCER RISK; CLINICAL ARTICLE; DOSIMETRY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; OBSERVATIONAL STUDY; PLANNING; PROSTATE CANCER; PROSTATE CARCINOMA; RADIATION CARCINOGENESIS; RADIATION INJURY; RECTUM CANCER; RISK ASSESSMENT; SMALL INTESTINE CANCER; THERMOLUMINESCENCE; THYROID CANCER; TREATMENT PLANNING;

ADULT; AGED; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RADIOTHERAPY DOSAGE;

EID: 79952425234     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.77082     Document Type: Article

References (32)

1. Hanks GE, Hanlon AL, Pinover WH, Horwitz EM, Schultheiss TE. Survival advantage for prostate cancer patients treated with highdose three-dimensional conformal radiotherapy. Cancer J Sci Am 1999;5:152-8. (Pubitemid 29252429)
2. Rischin D, Corry J, Smith J, Stewart J, Hughes P, Peters L. Excellent Disease Control and Survival in Patients With Advanced Nasopharyngeal Cancer Treated With Chemoradiation. J Clin Oncol 2002;20:1845-52. (Pubitemid 34273275)
3. Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001;166:876-81. (Pubitemid 32750970)
4. Kry S F, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA, et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005;62:1195-203. (Pubitemid 40884435)
5. Ruben JD, Davis S, Evans C, Jones P, Gagliardi F, Haynes M, et al. The Effect of Intensity-Modulated Radiotherapy on Radiation-Induced Second Malignancies. Int J Radiat Oncol Biol Phys 2008;70:1530-6.
6. Sharma SD, Upreti RR, Laskar S, Tambe CM, Deshpande DD, Shrivastava SK, et al. Estimation of risk of radiation-induced carcinogenesis in adolescents with nasopharyngeal cancer treated using sliding window IMRT. Radiother Oncol 2008;86:177-81.
7. Hall EJ. The inaugural frank ellis lecture - Iatrogenic cancer: The impact of intensity-modulated radiotherapy. Clin Oncol 2006;18:277-82.
8. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006;65:1-7.
9. Kry S F, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA, et al. Out-of-field photon and neutron dose equivalents from stepand-shoot intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2005;62:1204-16. (Pubitemid 40884436)
10. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation: United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) 2000 Report to the General Assembly. Bernan Assoc; 2001.
11. Dörr W, Herrmann T. Second primary tumors after radiotherapy for malignancies. Treatment-related parameters. Strahlenther Onkol 2002;178:357-62. (Pubitemid 34665782)
12. Schneider U, Zwahlen D, Ross D, Kaser-Hotz B. Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose. Int J Radiat Oncol Biol Phys 2005;61:1510-5. (Pubitemid 40470435)
13. Van Leeuwen FE, Klokman WJ, Veer MB, Hagenbeek A, Krol AD, Vetter UA, et al. Long-Term Risk of Second Malignancy in Survivors of Hodgkin's Disease Treated During Adolescence or Young Adulthood. J Clin Oncol 2000;18:487-97. (Pubitemid 30078530)
14. Nyandoto P, Muhonen T, Joensuu H. Second cancer among longterm survivors from Hodgkin's disease. Int J Radiat Oncol Biol Phys 1998;42:373-8. (Pubitemid 28502785)
15. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M. Risk of Second Brain Tumor after Conservative Surgery and Radiotherapy for Pituitary Adenoma: Update after an Additional 10 Years. J Clin Endocrinol Metab 2005;90:800-4. (Pubitemid 40279200)
16. Liauw SL, Sylvester JE, Morris CG, Blasko JC, Grimm PD. Second malignancies after prostate brachytherapy: Incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys 2006;66:669-73. (Pubitemid 44436687)
17. Kellen E, Zeegers M P, Dirx M, Houterman S, Droste J, Lawrence G, et al. Occurrence of both bladder and prostate cancer in five cancer registries in Belgium, The Netherlands and the United Kingdom. Euro J Cancer 2007;43:1694-700. (Pubitemid 47042369)
18. Boice Jr JD, Day NE, Andersen A, Brinton LA, Brown R, Choi N W, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst 1985;74:955-75. (Pubitemid 15062953)
19. Verellen D, Vanhavere F. Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region. Radiother Oncol 1999;53:199-203.
20. Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB, et al. Solid Cancers after Bone Marrow Transplantation. N Engl J Med 1997;336:897-904. (Pubitemid 27137189)
21. Preston DL, Ron E, Yonehara S, Kobuke T, Fujii H, Kishikawa M, et al. Tumors of the Nervous System and Pituitary Gland Associated With Atomic Bomb Radiation Exposure. J Natl Cancer Inst 2002;94:1555-63. (Pubitemid 35277279)
22. Ron E, Modan B, Boice J, Alfandary E, Stovall M, Chetrit A, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988;319:1033-9.
23. Tsang RW, Laperriere NJ, Simpson WJ, Brierley J, Panzarella T, Smyth HS. Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk. Cancer 1993;72:2227-33. (Pubitemid 23280152)
24. Cohen A, Rovelli A, Merlo DF, van Lint MT, Lanino E, Bresters D, et al. Risk for Secondary Thyroid Carcinoma After Hematopoietic Stem-Cell Transplantation: An EBMT Late Effects Working Party Study. J Clin Oncol 2007;25:2449-54. (Pubitemid 46999216)
25. Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): A nested case-control study. Lancet 2005;365:2014-23. (Pubitemid 40805009)
26. Brenner DJ, Curtis RE, Hall EJ, Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer 2000;88:398-406. (Pubitemid 30051826)
27. Boice JD, Engholm G, Kleinerman RA, Blettner M, Stovall M, Lisco H, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 1988;116:3-55.
28. Travis LB, Curtis RE, Boice JD, Platz CE, Hankey B F, Fraumeni JF. Second malignant neoplasms among long-term survivors of ovarian cancer. Cancer Res 1996;56:1564-70. (Pubitemid 26104020)
29. Travis L, Curtis R, Storm H, Hall P, Holowaty E, Van Leeuwen F, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 1997;89:1429-39. (Pubitemid 27419206)
30. Kleinerman RA, Boice JD Jr, Storm HH, Sparen P, Andersen A, Pukkala E, et al. Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer 1995;76:442-52.
31. Renner R. Hormesis. Nietzsche's toxicology. Sci Am 2003;289:28-30.
32. Suit H, Goldberg S, Niemierko A, Ancukiewicz M, Hall E, Goitein M, et al. Secondary carcinogenesis in patients treated with radiation: A review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res 2007;167:12-42. (Pubitemid 46106795)